CORBF (Global Cord Blood) ROC %: 21.05% (As of Mar. 2022)


CORBF Global Cord Blood Corp CORBF
12 GF Score
Price $0.95
View Full Analysis

What is Global Cord Blood ROC %?

Global Cord Blood CORBF 12 ROC % is 21.05% as of Mar. 2022. GuruFocus rates CORBF with a GF Score™ of 12/100.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Global Cord Blood's annualized return on capital (ROC %) for the quarter that ended in Mar. 2022 was 21.05%.

As of today (2026-06-25), Global Cord Blood's WACC % is 0.00%. Global Cord Blood's ROC % is 0.00% (calculated using TTM income statement data). Global Cord Blood earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Global Cord Blood  (OTCPK:CORBF) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Global Cord Blood's WACC % is 0.00%. Global Cord Blood's ROC % is 0.00% (calculated using TTM income statement data). Global Cord Blood earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Global Cord Blood ROC % Related Terms


Global Cord Blood ROC % Historical Data

* Premium members only.

The historical data trend for Global Cord Blood's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Global Cord Blood ROC % Chart

Global Cord Blood Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.03 16.72 23.61 23.77 24.31

Global Cord Blood Quarterly Data
Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.47 24.62 25.36 24.86 21.05
CORBF
12GF Score
Global Cord Blood Corp CORBF
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Global Cord Blood ROC % Calculation

Global Cord Blood's annualized Return on Capital (ROC %) for the fiscal year that ended in Mar. 2022 is calculated as:

ROC % (A: Mar. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Mar. 2021 ) + Invested Capital (A: Mar. 2022 ))/ count )
=95.966 * ( 1 - 18.85% )/( (316.266 + 324.36)/ 2 )
=77.876409/320.313
=24.31 %

where

Invested Capital(A: Mar. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1214.322 - 26.951 - ( 933.173 - max(0, 96.218 - 967.323+933.173))
=316.266

Invested Capital(A: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1345.164 - 29.655 - ( 1049.867 - max(0, 101.907 - 1093.056+1049.867))
=324.36

Global Cord Blood's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2022 is calculated as:

ROC % (Q: Mar. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2021 ) + Invested Capital (Q: Mar. 2022 ))/ count )
=89.612 * ( 1 - 23.75% )/( (324.871 + 324.36)/ 2 )
=68.32915/324.6155
=21.05 %

where

Invested Capital(Q: Dec. 2021 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1318.469 - 28.704 - ( 1021.308 - max(0, 99.932 - 1064.826+1021.308))
=324.871

Invested Capital(Q: Mar. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1345.164 - 29.655 - ( 1049.867 - max(0, 101.907 - 1093.056+1049.867))
=324.36

Note: The Operating Income data used here is four times the quarterly (Mar. 2022) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of 21.05% mean?
Global Cord Blood (CORBF) has a ROC % of 21.05% as of Mar. 2022. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Global Cord Blood and its competitors.
Is Global Cord Blood's ROC % too high?
Global Cord Blood's current ROC % is 21.05%. Overall, Global Cord Blood has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Global Cord Blood's ROC % compare to PRE and LMDX?
Global Cord Blood's ROC % of 21.05% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Diagnostics & Research company?
A good ROC % depends on the Medical Diagnostics & Research industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Global Cord Blood and its competitors. Global Cord Blood's current ROC % is 21.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Cord Blood stock overvalued right now?
Global Cord Blood (CORBF) has a current ROC % of 21.05%. The current ROC % is 21.05%. Global Cord Blood's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Global Cord Blood (CORBF), the current ROC % is 21.05% as of Mar. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Global Cord Blood Business Description

Address 1 Garden Road, 48th Floor, Bank of China Tower, Central, Hong Kong, HKG
Global Cord Blood Corp provides cord blood banking services. The company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments and technologies such as cord blood transplants. The company generates all of its revenues by providing subscribers with processing services, which consist of the testing and processing of cord blood units, and storage services, which consist of the storage of cord blood units in its facilities.
12GF Score

Get the complete analysis for CORBF

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.95
Price